Key Facts
Founding Year
2016
CEO
Branden RYU
Main Location
Boston, USA
Daejeon, Korea
Team members
101
(Ph.D. 30)
Total fundraising
78.5 million USD
Partners
Core technology
CNS targeted RNAi delivery system
Lead Program
BMD-001
(Neurodegenerative disease)
Achievements
- Quick fire challenge award in Neuroscience, Johnson & Johnson Innovation
- Endless Frontier Labs program graduation(US)
Certification
ISO 9001/13485
GMP Facility
Korea Venture Company
Last Updated: March, 2023